Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORAL, RECTALStandard

SODIUM POLYSTYRENE SULFONATE

SODIUM POLYSTYRENE SULFONATE

Standard Dose
454GM/BOT
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SODIUM POLYSTYRENE SULFONATE is listed in Drugs@FDA under application 206815 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM POLYSTYRENE SULFONATE Form and strength POWDER;ORAL, RECTAL - 454GM/BOT Sponsor CHARTWELL RX Submission history Latest submission status date: 2020-02-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM POLYSTYRENE SULFONATE is listed in Drugs@FDA under application 206815 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM POLYSTYRENE SULFONATE Form and strength POWDER;ORAL, RECTAL - 454GM/BOT Sponsor CHARTWELL RX Submission history Latest submission status date: 2020-02-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.